Methenamine for Recurrent Urinary Tract Infections in Solid Organ Transplantation.
Helen SweissSuverta BhayanaReed HallJoelle NelsonElisabeth KincaidePublished in: Progress in transplantation (Aliso Viejo, Calif.) (2021)
This evaluation supported methenamine therapy for recurrent urinary tract infection in kidney and liver-kidney transplant. The most significant impact of methenamine recurrent urinary tract infection was seen in the first 30 days after initiation.